Why Omega-3-Acid Ethyl Esters Matter: A Clinically Tested Solution for Severe Hypertriglyceridemia
🍔 In recent years, the prevalence of metabolic disorders has continued to rise, driven by…
News
NBP (Butylphthalide)—A Breakthrough in Neuroprotection for Ischemic
Acute ischemic stroke remains a major global health challenge, leading to high morbidity, mortality, and…
Luvometinib Tablets Approved in China 丨A Next-Generation MEK1/2 Inhibitor for Rare MAPK-Driven Tumors
China’s National Medical Products Administration (NMPA) has officially approved Luvometinib Tablets (brand name Fumaining®, development code…
Innovative Drug Delivery Systems: Transforming Modern Medicine
When it comes to medicine, most people assume that taking a drug is enough for…
Fosrolapitant and Palonosetron Hydrochloride Injection Receives Approval丨Offering New Hope for Chemotherapy-Induced Nausea and Vomiting Management
Recently, Fujian Shengdian Pharmaceutical Co., Ltd., a subsidiary of Hengrui Medicine, received approval from the…
What is Innovative Drug? Exploring the Future of Medicine
In the rapidly evolving field of healthcare, the term “innovative drug” has gained significant attention.…
How Strong Is China Innovative Drug Industry? China Emerges as a Global Pharma Innovation Powerhouse
How strong is China innovative drug industry? The answer is increasingly evident as the nation…
China Pharma Distribution Trends 2025: Key Insights and Predictions
The landscape of China pharma distribution trends 2025 is set to experience remarkable transformation as…
How to Import Medicines from China: A Complete 2025 Guide for Global Pharmaceutical Buyers
In recent years, the question “How to Import Medicines from China” has become one of…
Zanidatamab Injection (ZIIHERA) Approved in China for HER2-Positive Advanced Biliary Tract Cancer
May 29, 2025 — The National Medical Products Administration (NMPA) has granted conditional approval through…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights